News
Press release: Leonteq launches collaboration with Ixios
Press release: Leonteq launches collaboration with Ixios
Leclanché SA: Leclanché achieves significant breakthrough in safety of its lithium-ion battery technology with no compromise to cell performance
Leclanché SA: Leclanché achieves significant breakthrough in safety of its lithium-ion battery technology with no compromise to cell performance
HBM Healthcare Investments Ltd concludes 2019 share buyback programme and launches new share buyback programme
HBM Healthcare Investments Ltd concludes 2019 share buyback programme and launches new share buyback programme
DKSH Performance Materials Strengthens its Life Sciences Capabilities by Acquiring Refarmed Group
DKSH Performance Materials Strengthens its Life Sciences Capabilities by Acquiring Refarmed Group
Kinarus Therapeutics to host KOL event on Monday, June 27, to discuss therapies in wet Age-Related Macular Degeneration and potential advantages of KIN001
Kinarus Therapeutics to host KOL event on Monday, June 27, to discuss therapies in wet Age-Related Macular Degeneration and potential advantages of KIN001
LEM announces inauguration ceremony for new production plant in Malaysia
LEM announces inauguration ceremony for new production plant in Malaysia
Swiss Prime Site Immobilien: strong letting performance in H1 2022
Swiss Prime Site Immobilien: strong letting performance in H1 2022
Products that create value and reduce the ecological footprint
Products that create value and reduce the ecological footprint
Ad hoc announcement pursuant to Article 53 LR - AGM 2022 approves proposals of the Board of Directors
Ad hoc announcement pursuant to Article 53 LR - AGM 2022 approves proposals of the Board of Directors
Lindt & Sprüngli completes buyback of own shares and participation certificates
Lindt & Sprüngli completes buyback of own shares and participation certificates
Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001
Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001
Schindler commits to full-scope net-zero emissions by 2040
Schindler commits to full-scope net-zero emissions by 2040
Lindt & Sprüngli publishes 2021 Sustainability Report and adds cocoa butter to its Farming Program
Lindt & Sprüngli publishes 2021 Sustainability Report and adds cocoa butter to its Farming Program
Invitation Audio Webcast Presentation of Bossard's semi-annual results 2022
Invitation Audio Webcast
Presentation of Bossard's semi-annual results 2022
Successful closing of Bellevue Entrepreneur Private Strategy – Bellevue Private Markets segment continues to grow
Successful closing of Bellevue Entrepreneur Private Strategy – Bellevue Private Markets segment continues to grow
Leclanché Announces Development of Third-Generation Marine Battery System for Electrification of Broad Range of Vessels
Leclanché Announces Development of Third-Generation Marine Battery System for Electrification of Broad Range of Vessels
Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
Cicor expects around 30 percent growth in the first half-year due to strong business performance
Cicor expects around 30 percent growth in the first half-year due to strong business performance